Walleye Trading’s Clover Health Investments CLOV Stock Holding History

Walleye Trading’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$469K	Buy	89,500 +37,900	+73%	+$129K	﹤0.01%	2724
2026 Q1	$90.8K	Buy	51,600 +29,600	+135%	+$64.2K	﹤0.01%	3492
2025 Q4	$51.7K	Buy	22,000 +19,700	+857%	+$53.8K	﹤0.01%	3948
2025 Q3	$7.04K	Sell	2,300 -16,100	-88%	-$46K	﹤0.01%	4224
2025 Q2	$51.3K	Buy	18,400 +18,300	+18,300%	+$60.2K	﹤0.01%	3813
2025 Q1	$359	Buy	+100	New	+$402	﹤0.01%	3966
2024 Q1	–	Sell	-16,300	Closed	-$15.5K	–	4830
2023 Q4	$15.5K	Buy	+16,300	New	+$16K	﹤0.01%	4541
2022 Q2	–	Sell	-2,400	Closed	-$9K	–	5180
2022 Q1	$9K	Buy	+2,400	New	+$6.96K	﹤0.01%	4973
2021 Q4	–	Sell	-33,500	Closed	-$248K	–	5408
2021 Q3	$248K	Buy	33,500 +1,700	+5%	+$14.5K	﹤0.01%	3647
2021 Q2	$424K	Buy	+31,800	New	+$312K	﹤0.01%	3091

Other funds holding CLOV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Walleye Trading's CLOV Position: Q2 2026 in Review

Walleye Trading reduced its Clover Health Investments (CLOV) stake by 47% in Q2 2026, selling an estimated $158K and leaving 53,028 shares worth $278K. The position accounts for ﹤0.01% of the portfolio, ranked #2966.

Walleye Trading first reported a position in CLOV in Q2 2020 and has held it in 9 quarters since. The position peaked at $2.22M in Q2 2020. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

Walleye Trading held 53,028 shares of Clover Health Investments worth $278K as of Q2 2026.
Walleye Trading sold 46,455 Clover Health Investments shares in Q2 2026, an estimated $158K.
Clover Health Investments made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #2966 holding.
Walleye Trading first reported a position in Clover Health Investments in Q2 2020 and has held it in 9 quarters since.
Walleye Trading's Clover Health Investments position peaked at $2.22M in Q2 2020.
227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.